38 / 48
38
WFSBP 2017
Preliminary Scientific Programme /
Workshops
T11: DEPRESSION: BASIC/CLINICAL
WS-07
15:00–16:30
Merging evidence and clinical practice in management
of depression: The CANMAT experience
Chair:
Sidney Kennedy, Canada
Co-Chair: Roumen Milev, Canada
WS-07-001
Guidelines for Pharmacological Management of
Depression
Raymond Lam, Canada
WS-07-002
Making Effective Guidelines: Examples of Evidence-
based Dissemination and Implementation Strategies
Sagar Parikh, USA
WS-07-003
Guidelines for the treatment of depression in specific
populations: making decisions despite gaps in evidence
Glenda MacQueen, Canada
WS-07-004
Guidelines for the use of complementary and alternative
medicines ( CAM ) in major depression
Arun Ravindran, Canada
T51: NEUROPSYCHOPATHOLOGY
WS-08
15:00–16:30
Functional neuroanatomy of hallucinations
Chair:
Rajesh Nagpal, India
Co-Chair: Harishchandra Gambheera, Sri Lanka
WS-08-001
Functional neuroanatomy of auditory hallucinations
E. Mohandas Warrier, India
WS-08-002
Neural signature of visual hallucinations
Venu Gopal Jhanwar, India
WS-08-003
Neural mechanisms of somatic, musical and extracamp-
ine hallucinations
Anukant Mital, India
WS-08-004
The neural signature overlap between delusions and
hallucinations
Debashis Ray, India
aa
Wednesday, 21 June 2017
T43: SCHIZOPHRENIA: BASIC/CLINICAL
WS-09
11:15–12:45
Schizophrenia research in Chile
Chair:
Hernan Silva, Chile
Co-Chair: Veronica Larach, Chile
WS-09-001
BDNF as a biomarker of cognitive function in schizo-
phrenia: A study in Chilean population
Hernan Silva, Chile
WS-09-002
Pragmatic and linguistic disorders in schizophrenia
since the first episode
Eduardo Duran, Chile
WS-09-003
Atypical antipsychotics and psychosis spectrum: Chilean
experience
Eugenio Olea, Chile
WS-09-004
Universal coverage for schizophrenia: The GES pro-
gramme in Chile
Veronica Larach, Chile
T43: SCHIZOPHRENIA: BASIC/CLINICAL
WS-10
15:00–16:30
Evidence for brain stimulation methods in
schizophrenia
Chair:
Joachim Cordes, Germany
Co-Chair: Christian Plewnia, Germany
WS-10-001
Effects of transcranial direct current stimulation (tDCS)
on executive functions
Christian Plewnia, Germany
WS-10-002
rTMS for the treatment of negative symptoms in residual
schizophrenia
Joachim Cordes, Germany
WS-10-003
The treatment of hallucinations in schizophrenia spec-
trum disorders
Iris Sommer, The Netherlands
WS-10-004
Predictors of response to ECT in treatment-resistant
schizophrenia
Tomasz Pawelczyk, Poland
TUE WED